| Bildiri Türü | Tebliğ/Bildiri | Bildiri Dili | İngilizce |
| Bildiri Alt Türü | Özet Metin Olarak Yayınlanan Tebliğ (Uluslararası Kongre/Sempozyum) | ||
| Bildiri Niteliği | Web of Science Kapsamındaki Kongre/Sempozyum | ||
| DOI Numarası | 10.1183/13993003.congress-2019.PA1162 | ||
| Kongre Adı | Physiotherapists | ||
| Kongre Tarihi | 28-09-2019 / 02-10-2019 | ||
| Basıldığı Ülke | Basıldığı Şehir | ||
| Bildiri Linki | http://erj.ersjournals.com/lookup/doi/10.1183/13993003.congress-2019.PA1162 | ||
| UAK Araştırma Alanları |
Fizyoterapi ve Rehabilitasyon
|
||
| Özet |
| Background: Cancer treatments may impair pulmonary function, respiratory muscle strength, and activities of daily life (ADL) in breast cancer survivors.Aim: The purpose was to investigate pulmonary function, respiratory muscle strength, and ADL performance in breast cancer survivors.Methods: Fifteen breast survivors (15F, age: 60.9±8.70 years) who underwent mastectomy or completed chemotherapy and/or radiotherapy treatment, without any metastasis or active disease were included. Spirometric measurements were performed. Respiratory muscle strength was measured using a portable mouthpiece pressure device. The ADL performance was assessed using Glittre ADL test.Results: The FEV1 was found to be 94.1±10.5% pred. The mean maximal inspiratory (MIP) and expiratory pressure (MEP) were 84.0±20.7 cmH2O and 101.9±26.2 cmH2O, respectively. The percentage of predicted of MIP and MEP were … |
| Anahtar Kelimeler |
| Respiratory muscle |
| Atıf Sayıları | |
| Google Scholar | 1 |